Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 6 studies | 25% ± 9% | |
epithelial cell | 3 studies | 20% ± 4% | |
hepatocyte | 3 studies | 43% ± 19% | |
GABAergic neuron | 3 studies | 48% ± 22% | |
astrocyte | 3 studies | 30% ± 10% | |
glutamatergic neuron | 3 studies | 51% ± 26% | |
oligodendrocyte precursor cell | 3 studies | 37% ± 27% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 39% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 397.34 | 89 / 89 | 89% | 2.79 | 805 / 901 |
prostate | 100% | 164.84 | 244 / 245 | 89% | 1.81 | 449 / 502 |
stomach | 99% | 150.43 | 356 / 359 | 86% | 2.00 | 245 / 286 |
ovary | 98% | 68.41 | 176 / 180 | 87% | 2.12 | 372 / 430 |
liver | 100% | 575.37 | 226 / 226 | 84% | 2.02 | 340 / 406 |
pancreas | 100% | 324.91 | 328 / 328 | 78% | 1.46 | 138 / 178 |
intestine | 99% | 124.85 | 959 / 966 | 76% | 1.59 | 401 / 527 |
lung | 97% | 122.47 | 562 / 578 | 77% | 1.89 | 894 / 1155 |
esophagus | 97% | 126.99 | 1408 / 1445 | 76% | 1.79 | 139 / 183 |
thymus | 100% | 165.31 | 653 / 653 | 71% | 1.18 | 429 / 605 |
bladder | 90% | 138.10 | 19 / 21 | 71% | 1.83 | 360 / 504 |
breast | 88% | 107.33 | 406 / 459 | 69% | 1.40 | 768 / 1118 |
uterus | 98% | 77.42 | 167 / 170 | 51% | 0.97 | 234 / 459 |
adrenal gland | 100% | 392.41 | 258 / 258 | 47% | 1.01 | 109 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.57 | 1 / 1 |
spleen | 95% | 58.44 | 229 / 241 | 0% | 0 | 0 / 0 |
brain | 92% | 81.82 | 2441 / 2642 | 2% | 0.03 | 15 / 705 |
skin | 81% | 79.71 | 1471 / 1809 | 13% | 0.21 | 60 / 472 |
heart | 83% | 53.14 | 717 / 861 | 0% | 0 | 0 / 0 |
adipose | 69% | 38.92 | 836 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 63.26 | 582 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 42% | 0.84 | 19 / 45 |
muscle | 39% | 18.33 | 317 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 25% | 9.50 | 335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.21 | 5 / 29 |
eye | 0% | 0 | 0 / 0 | 13% | 0.16 | 10 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008150 | Biological process | biological_process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0051015 | Molecular function | actin filament binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | ACTR3C |
Protein name | Actin related protein 3C Actin-related protein 3C (Actin-related protein 11) |
Synonyms | ARP11 |
Description | FUNCTION: May play a role in the suppression of metastatic potential in lung adenoma carcinoma cells. . |
Accessions | Q9C0K3 ENST00000683684.1 [Q9C0K3-1] ENST00000539352.5 ENST00000252071.8 [Q9C0K3-1] ENST00000477367.1 ENST00000477871.1 C9IZN3 H7C4J1 ENST00000478393.5 A0A0A0MTI9 C9J580 |